Skip to main content
. 2025 Aug 12;16:1645412. doi: 10.3389/fimmu.2025.1645412

Table 3.

Adverse events.

Adverse Events Grade I-II (%) Grade III-IV (%)
Immuno-related (n = 26)
 Rash 2 (7.7) 0 (0)
 Hypothyroidism 0 (0) 1 (3.8)
 Adrenocortical insufficiency 1 (3.8) 0 (0)
 Myocarditis 1 (3.8) 0 (0)
 Increased aminotransferase 1 (3.8) 0 (0)
 Gastrointestinal reaction 2 (7.7) 0 (0)
Surgery-related (n = 26)
 Anastomotic leak 1 (3.8) 0 (0)
 Obstruction/Ileus 2 (7.7) 0 (0)
 Infection 1 (3.8) 0 (0)
 Bleeding 1 (3.8) 0 (0)